Pharmacological inhibition of MMP9 during development or genetic reduction of MMP9 in these mice restores PNN levels and reduces anxiety [70, 71], supporting the hypothesis that elevated MMP9 during development reduces CSPGs, impairs PNN development and in turn destabilizes synapses during this developmental window. Here, MMP9 is linked to Anxiety.